Skip to content

Isomorphic Labs Raises $5 Billion in Series C Funding for AI Drug Development

2 reports 2 reporting sources first reported Updated 17 hours ago

Understand the event

AI overview

Isomorphic Labs has raised $5 billion in a Series C funding round to advance its drug candidates toward clinical trials. This capital was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and the company's existing investors. The AI drug-discovery platform, which spun out of Google's DeepMind in 2021, stated that it has already achieved positive preclinical results in oncology and immunology. CEO Demis Hassabis described the funding as a step toward the company's mission to use AI to "Solve All Disease," with the goal of radically reducing the time and cost required to discover new medicines. Following this investment, the company plans to continue developing its core drug-design engine and intends to expand its research into further types of medicine.

Generated by AI from reports · Updated 14 hours ago

Read next

More changes in today’s briefingOpenAI Introduces GPT-6.2 Astra and Sol

Report timeline

Follow the reports to explore different sides of the event.

11/17
  1. Isomorphic Labs Raises $5 Billion to Advance Drug Candidates Toward Clinical Trials

    Isomorphic Labs has raised $5 billion in a Series C round to advance its drug candidates toward clinical trials. The funding was co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz and existing backers also participating. The company said its program has produced positive preclinical results in oncology and immunology; it plans to keep developing its drug-design engine and expand into more types of medicine.

  2. Thrilled to announce $5B in funding for @IsomorphicLabs to accelerate our mission to Solve All Disease. We continue to make rapid progress reimagining drug design from first principles with AI to radically cut the time & cost to find new medicines. Gradually, then all at once...

    Thrilled to announce $5B in funding for @IsomorphicLabs to accelerate our mission to Solve All Disease. We continue to make rapid progress reimagining drug design from first principles with AI to radically cut the time & cost to find new medicines. Gradually, then all at once...

Keep up with AI, one email a day

Model releases, price changes and compute developments, with original sources. Free, confirmed by email, and easy to unsubscribe. Read a past issue

Event heat trend

Current within comparable coverage
18
Peak within comparable coverage
2811/17 23:00 (UTC+8)
24-hour change
–

Trends compare the same continuously observed participants, which may cover fewer sources than current heat. Point or click to inspect hourly heat, or use left and right arrow keys.